LYRM2 and hepatocellular carcinoma: Additionally, Ki‐67 and IHC staining for E‐cadherin, N‐cadherin and Vimentin in xenograft tumours revealed that the suppression of LYRM2 in HCC cells inhibited both the cell proliferation and EMT.